EIP
TMO icon

Epoch Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Epoch Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,214
Closed -$22.2M – 240
2026
Q1 		$22.2M Sell
45,214
-4,505
-9% -$2.44M 0.13% 174
2025
Q4 		$28.8M Sell
49,719
-14,290
-22% -$8.08M 0.16% 162
2025
Q3 		$31M Sell
64,009
-17,399
-21% -$8.1M 0.17% 161
2025
Q2 		$33M Sell
81,408
-53,867
-40% -$22.5M 0.17% 158
2025
Q1 		$67.3M Sell
135,275
-11,816
-8% -$6.4M 0.35% 108
2024
Q4 		$76.5M Sell
147,091
-99,088
-40% -$54.5M 0.37% 97
2024
Q3 		$152M Sell
246,179
-77,089
-24% -$45.6M 0.68% 43
2024
Q2 		$179M Buy
323,268
+5,295
+2% +$3.03M 0.82% 29
2024
Q1 		$185M Sell
317,973
-25,998
-8% -$14.6M 0.82% 25
2023
Q4 		$183M Buy
343,971
+145,858
+74% +$70.6M 0.83% 18
2023
Q3 		$100M Buy
198,113
+23,218
+13% +$12.4M 0.64% 42
2023
Q2 		$91.3M Sell
174,895
-739
-0.4% -$399K 0.53% 56
2023
Q1 		$101M Sell
175,634
-16,325
-9% -$9.2M 0.6% 46
2022
Q4 		$106M Buy
191,959
+47,976
+33% +$25.4M 0.63% 41
2022
Q3 		$73M Buy
143,983
+777
+0.5% +$435K 0.48% 70
2022
Q2 		$77.8M Sell
143,206
-22,035
-13% -$12.1M 0.46% 72
2022
Q1 		$97.6M Sell
165,241
-3,158
-2% -$1.81M 0.48% 69
2021
Q4 		$112M Sell
168,399
-150,822
-47% -$94.2M 0.57% 50
2021
Q3 		$182M Buy
319,221
+17,287
+6% +$9.49M 1.01% 23
2021
Q2 		$152M Sell
301,934
-90,426
-23% -$42.7M 0.82% 32
2021
Q1 		$179M Sell
392,360
-57,853
-13% -$27.6M 0.84% 30
2020
Q4 		$210M Sell
450,213
-95,072
-17% -$44.6M 0.96% 25
2020
Q3 		$241M Sell
545,285
-29,233
-5% -$12.1M 1.2% 14
2020
Q2 		$208M Buy
+574,518
New +$193M 1.07% 18
2014
Q1 		– Sell
-759,541
Closed -$84.6M – 285
2013
Q4 		$84.6M Sell
759,541
-123,326
-14% -$12.3M 0.36% 92
2013
Q3 		$81.4M Buy
882,867
+3,086
+0.4% +$279K 0.36% 100
2013
Q2 		$74.5M Buy
+879,781
New +$73.2M 0.37% 101

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Epoch Investment Partners's TMO Position: Q2 2026 in Review

Epoch Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 45,214 shares — an estimated $22.2M sold.

Epoch Investment Partners first reported a position in TMO in Q2 2013 and held it in 27 quarters. The position peaked at $241M in Q3 2020. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Epoch Investment Partners reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Epoch Investment Partners sold 45,214 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.2M.
  • Epoch Investment Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 27 quarters.
  • Epoch Investment Partners's Thermo Fisher Scientific position peaked at $241M in Q3 2020.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.